Pharma-Bio Serv Inc PBSV Stock Analysis
- PINK
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.40 down $0.04, 9.90% at close Nov 6
Last close · Previous close $0.45
- Market cap
- At the Nov 6 close
- Dividend yield
- 18.68%Last 12 months
Price chart
$0.40down $0.06, 13.30%Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.45Nov 5
- Volume15.68KNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume2.28KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.32 to $0.60; now $0.40
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
PBSV trailed the S&P 500 in all 7 periods.
| Period | PBSV and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | PBSV: down 13.3% S&P 500: down 5.6% | PBSV trailed the S&P 500 by 7.7 percentage points Trailed |
| 3M | PBSV: down 30.8% S&P 500: down 4.1% | PBSV trailed the S&P 500 by 26.7 percentage points Trailed |
| YTD | PBSV: down 22.8% S&P 500: up 8.7% | PBSV trailed the S&P 500 by 31.5 percentage points Trailed |
| 1Y | PBSV: down 13.9% S&P 500: up 10.9% | PBSV trailed the S&P 500 by 24.8 percentage points Trailed |
| Long term | ||
| 3Y | PBSV: down 34.7% S&P 500: up 75.0% −13.2% vs +20.5% a year | PBSV trailed the S&P 500 by 109.7 percentage points Trailed |
| 5Y | PBSV: down 34.0% S&P 500: up 67.8% −8.0% vs +10.9% a year | PBSV trailed the S&P 500 by 101.8 percentage points Trailed |
| 10Y | PBSV: up 21.2% S&P 500: up 313.1% +1.9% vs +15.2% a year | PBSV trailed the S&P 500 by 291.9 percentage points Trailed |
$10,000 invested in PBSV 10 years ago (Nov 4, 2016) would be worth about $12,121 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
PBSV trailed the S&P 500 in all 7 periods.
| Period | PBSV and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | PBSV: down 13.3% S&P 500: down 5.6% | PBSV trailed the S&P 500 by 7.7 percentage points Trailed |
| 3M | PBSV: down 30.8% S&P 500: down 4.3% | PBSV trailed the S&P 500 by 26.5 percentage points Trailed |
| YTD | PBSV: down 33.1% S&P 500: up 7.8% | PBSV trailed the S&P 500 by 40.9 percentage points Trailed |
| 1Y | PBSV: down 25.3% S&P 500: up 9.7% | PBSV trailed the S&P 500 by 35.0 percentage points Trailed |
| Long term | ||
| 3Y | PBSV: down 53.3% S&P 500: up 68.8% −22.4% vs +19.1% a year | PBSV trailed the S&P 500 by 122.1 percentage points Trailed |
| 5Y | PBSV: down 62.1% S&P 500: up 56.9% −17.6% vs +9.4% a year | PBSV trailed the S&P 500 by 119.0 percentage points Trailed |
| 10Y | PBSV: down 43.5% S&P 500: up 252.6% −5.5% vs +13.4% a year | PBSV trailed the S&P 500 by 296.1 percentage points Trailed |
$10,000 invested in PBSV 10 years ago (Nov 4, 2016) would be worth about $5,655 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$2.19
Closing high on . Now 81.7% below that record.
Split-adjusted daily closes since Dec 4, 2006.
Stock splits
PBSV hasn’t split since its price history begins in 2006.
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY21, the quarter ended Apr 30, 2021, and balance-sheet figures are as of Apr 30, 2021. 12-month figures aren’t available until four quarters are reported.
Revenue and net income
12-month figures aren’t available until four quarters are reported.
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY20 (Oct 31, 2020) | $5.03M | $144.35K | $0.01 |
| Q1 FY21 (Jan 31, 2021) | $4.49M | $268.03K | $0.01 |
| Q2 FY21 (Apr 30, 2021) | $5.04M | $240.27K | $0.01 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY20 (Oct 31, 2020) | $21.56M | $2.05M | $0.09 |
Margins
- Gross
- Operating
- Net
The lines show each quarter. What margins tell you
Cash flow
12-month figures aren’t available until four quarters are reported.
Shareholder returns
12-month figures aren’t available until four quarters are reported.
Balance sheet
- $16.07KAs of Apr 30, 2021
Cash plus short- and long-term marketable securities on the Apr 30, 2021 balance sheet.
- Total debt$2.66MAs of Apr 30, 2021
- Net debt$2.65MAs of Apr 30, 2021
- 8.16As of Apr 30, 2021
Current assets divided by current liabilities on the Apr 30, 2021 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.12As of Apr 30, 2021
Total debt divided by shareholders’ equity on the Apr 30, 2021 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
12-month figures aren’t available until four quarters are reported.
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $0.000 |
| 2017 | $0.000 |
| 2018 | $0.075 |
| 2019 | $0.075 |
| 2020 | $0.000 |
| 2021 | $0.15 |
| 2022 | $0.075 |
| 2023 | $0.075 |
| 2024 | $0.075 |
| 2025 | $0.075 |
| 2026 (to date) | $0.075 |
Dividend details
- $0.08Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- Dividend yield18.68%Last 12 months
- $0.075Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
- FrequencyAnnual1 payment in the last 12 months
About Pharma-Bio Serv Inc
Pharma-Bio Serv services the Puerto Rico, United States, Europe and Latin America markets. Pharma-Bio Serv's core business is FDA and international agencies regulatory compliance consulting related services. The Company's global team includes leading engineering and life science professionals, quality assurance managers and directors.
- Sector
- Industrials
- Industry
- Consulting Services
- Headquarters
- Puerto Rico
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- PINK
- Asset type
- Common stock
- Price history since
PBSV news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
PBSV stock FAQ
What is PBSV stock’s price today?
Pharma-Bio Serv (PBSV) traded at $0.40 at the close on , down $0.04 (9.90%) from the previous close of $0.45. Over the past 52 weeks it has traded between $0.32 and $0.60.
If you invested $1,000 in PBSV 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in PBSV on would be worth about $1,212 at the close on , a total return of +21.2%. The same $1,000 would be worth $660 if invested five years ago and $861 if invested one year ago. Past performance doesn’t predict future returns.
Does PBSV pay a dividend?
Yes. Pharma-Bio Serv pays a annual dividend. The most recent was $0.075 per share, with an ex-dividend date of . Over the last twelve months it paid $0.08 per share, a 18.68% yield at the close (how dividend yield works).
Based on the last 12 months’ payments ($0.08 per share), and if the next 12 months match the last 12, 100 shares would receive about $8 over 12 months, and $1,000 over 12 months would take about 13,334 shares, roughly $5,354 at the close. Dividends can change.
What is PBSV’s 52-week high and low?
Over the past 52 weeks PBSV has traded as low as $0.32 and as high as $0.60. At $0.40 at the close on , it is 33.1% below that high and 25.5% above the low.
What is PBSV’s all-time high?
PBSV’s highest closing price was $2.19 on , adjusted for stock splits. At $0.40 at the close on , it is 81.7% below that record.
Has PBSV stock ever split?
No. PBSV hasn’t split since its price history begins in 2006.
How has PBSV stock performed?
Including dividends and measured to the close on , PBSV has returned −22.8% so far this year and −13.9% over the past year, and −34.0% over five years (−8.0% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is Pharma-Bio Serv in?
Pharma-Bio Serv is in the Industrials sector and the Consulting Services industry, and is headquartered in Puerto Rico.
What exchange does PBSV trade on?
Pharma-Bio Serv trades on the PINK under the ticker symbol PBSV. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.